CPHRF - Cipher Pharmaceuticals GAAP EPS of C$0.08 revenue of C$5.4M May, 12 2022 05:24 PM Companhia Siderurgica Paulista Nova Cosipa Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q1 GAAP EPS of C$0.08. Revenue of C$5.4M (flat Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.08, revenue of C$5.4M